Cargando…
Systematic approach identifies RHOA as a potential biomarker therapeutic target for Asian gastric cancer
Gastric cancer (GC) is a highly heterogeneous disease, in dire need of specific, biomarker-driven cancer therapies. While the accumulation of cancer “Big Data” has propelled the search for novel molecular targets for GC, its specific subpathway and cellular functions vary from patient to patient. In...
Autores principales: | Chang, Hae Ryung, Nam, Seungyoon, Lee, Jinhyuk, Kim, Jin-Hee, Jung, Hae Rim, Park, Hee Seo, Park, Sungjin, Ahn, Young Zoo, Huh, Iksoo, Balch, Curt, Ku, Ja-Lok, Powis, Garth, Park, Taesung, Jeong, Jin-Hyun, Kim, Yon Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348404/ https://www.ncbi.nlm.nih.gov/pubmed/27806312 http://dx.doi.org/10.18632/oncotarget.12963 |
Ejemplares similares
-
Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems
por: Chang, Hae Ryung, et al.
Publicado: (2016) -
Second-Generation JK-206 Targets the Oncogenic Signal Mediator RHOA in Gastric Cancer
por: Beak, Myeonghun, et al.
Publicado: (2022) -
Network Comparison of Inflammation in Colorectal Cancer and Alzheimer's Disease
por: Park, Sungjin, et al.
Publicado: (2015) -
CANcer-specific Evaluation System (CANES): a high-accuracy platform, for preclinical single/multi-biomarker discovery
por: Kwon, Min-Seok, et al.
Publicado: (2017) -
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer
por: Chang, Hae Ryung, et al.
Publicado: (2016)